ETF Holdings Breakdown of BIIB

News associated with BIIB

LPL Financial LLC Sells 20,253 Shares of Biogen Inc. (NASDAQ:BIIB)

LPL Financial LLC cut its stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 43.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 26,138 shares of the biotechnology company’s stock after selling 20,253 shares during the quarter. LPL […] - 2025-04-11 07:49:04

Alliancebernstein L.P. Has $27.64 Million Holdings in Biogen Inc. (NASDAQ:BIIB)

Alliancebernstein L.P. boosted its position in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 0.9% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 180,723 shares of the biotechnology company’s stock after purchasing an additional 1,592 shares during the period. Alliancebernstein L.P. owned […] - 2025-04-07 10:12:53

American Century Companies Inc. Sells 101,604 Shares of Biogen Inc. (NASDAQ:BIIB)

American Century Companies Inc. lessened its position in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 46.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 115,374 shares of the biotechnology company’s stock after selling 101,604 shares during the period. American Century Companies Inc.’s […] - 2025-04-01 08:00:56

Comparing Biogen (NASDAQ:BIIB) and MiNK Therapeutics (NASDAQ:INKT)

Biogen (NASDAQ:BIIB – Get Free Report) and MiNK Therapeutics (NASDAQ:INKT – Get Free Report) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, institutional ownership, dividends, profitability and risk. Valuation and Earnings This table compares Biogen and MiNK […] - 2025-03-25 05:56:46

Biogen Inc. (NASDAQ:BIIB) Shares Sold by Commonwealth Equity Services LLC

Commonwealth Equity Services LLC trimmed its holdings in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 7.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 26,292 shares of the biotechnology company’s stock after selling 2,051 shares during the quarter. Commonwealth Equity Services […] - 2025-03-24 08:44:56

Nasdaq 100 Movers: MSTR, BIIB

In early trading on Tuesday, shares of Biogen topped the list of the day's best performing components of the Nasdaq 100 index, trading up 1.2%. Year to date, Biogen has lost about 5.0% of its value. And the worst performing Nasdaq 100 component thus far on the day is MicroStra - 2025-03-18 14:32:40

Atria Investments Inc Has $279,000 Stock Position in Biogen Inc. (NASDAQ:BIIB)

Atria Investments Inc lowered its stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 48.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,823 shares of the biotechnology company’s stock after selling 1,715 shares during the quarter. Atria Investments Inc’s holdings in […] - 2025-03-18 07:44:51

Brokerages Set Biogen Inc. (NASDAQ:BIIB) Price Target at $213.33

Biogen Inc. (NASDAQ:BIIB – Get Free Report) has been given a consensus recommendation of “Hold” by the thirty research firms that are covering the stock, Marketbeat reports. Seventeen investment analysts have rated the stock with a hold recommendation and thirteen have given a buy recommendation to the company. The average 1-year price target among brokerages […] - 2025-03-17 05:54:52

Allworth Financial LP Sells 633 Shares of Biogen Inc. (NASDAQ:BIIB)

Allworth Financial LP lowered its holdings in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 53.6% during the fourth quarter, Holdings Channel reports. The firm owned 548 shares of the biotechnology company’s stock after selling 633 shares during the period. Allworth Financial LP’s holdings in Biogen were worth $78,000 as of its most recent […] - 2025-02-25 08:32:55

Analysts Set Biogen Inc. (NASDAQ:BIIB) Price Target at $211.96

Shares of Biogen Inc. (NASDAQ:BIIB – Get Free Report) have earned an average recommendation of “Hold” from the thirty research firms that are covering the firm, MarketBeat.com reports. Seventeen investment analysts have rated the stock with a hold recommendation and thirteen have assigned a buy recommendation to the company. The average 12-month target price among […] - 2025-02-20 06:46:47

New Mexico Educational Retirement Board Decreases Stake in Biogen Inc. (NASDAQ:BIIB)

New Mexico Educational Retirement Board decreased its stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 2.8% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 6,924 shares of the biotechnology company’s stock after selling 200 shares during the quarter. New Mexico […] - 2025-02-18 09:45:08

William Blair Comments on Biogen’s Q2 Earnings (NASDAQ:BIIB)

Biogen Inc. (NASDAQ:BIIB – Free Report) – Research analysts at William Blair boosted their Q2 2025 earnings estimates for Biogen in a research report issued to clients and investors on Wednesday, February 12th. William Blair analyst M. Minter now anticipates that the biotechnology company will earn $4.20 per share for the quarter, up from their […] - 2025-02-17 08:32:45

Biogen Inc. (NASDAQ:BIIB) Shares Bought by Savant Capital LLC

Savant Capital LLC raised its position in Biogen Inc. (NASDAQ:BIIB – Free Report) by 11.3% during the 4th quarter, HoldingsChannel.com reports. The firm owned 4,179 shares of the biotechnology company’s stock after acquiring an additional 423 shares during the period. Savant Capital LLC’s holdings in Biogen were worth $639,000 at the end of the most […] - 2025-02-16 12:33:00

Choreo LLC Has $205,000 Stock Position in Biogen Inc. (NASDAQ:BIIB)

Choreo LLC cut its stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 23.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,360 shares of the biotechnology company’s stock after selling 422 shares during the period. Choreo […] - 2025-02-16 11:38:53

Bleakley Financial Group LLC Boosts Stake in Biogen Inc. (NASDAQ:BIIB)

Bleakley Financial Group LLC raised its stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 49.9% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,608 shares of the biotechnology company’s stock after acquiring an additional 535 shares during the […] - 2025-02-12 09:34:49

Biogen (NASDAQ:BIIB) Coverage Initiated at Sanford C. Bernstein

Sanford C. Bernstein began coverage on shares of Biogen (NASDAQ:BIIB – Free Report) in a research note issued to investors on Tuesday, Marketbeat.com reports. The brokerage issued a market perform rating and a $160.00 target price on the biotechnology company’s stock. A number of other analysts also recently issued reports on the stock. BMO Capital […] - 2025-02-12 08:32:58

Chicago Partners Investment Group LLC Has $369,000 Stock Position in Biogen Inc. (NASDAQ:BIIB)

Chicago Partners Investment Group LLC raised its holdings in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 71.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,445 shares of the biotechnology company’s stock after purchasing an additional 1,015 shares […] - 2025-02-05 09:04:48

Biogen Inc. (NASDAQ:BIIB) Shares Sold by Fifth Third Bancorp

Fifth Third Bancorp reduced its stake in Biogen Inc. (NASDAQ:BIIB – Free Report) by 3.4% in the fourth quarter, HoldingsChannel reports. The fund owned 3,246 shares of the biotechnology company’s stock after selling 113 shares during the quarter. Fifth Third Bancorp’s holdings in Biogen were worth $496,000 at the end of the most recent reporting […] - 2025-01-31 10:20:57

Exchange Traded Concepts LLC Boosts Position in Biogen Inc. (NASDAQ:BIIB)

Exchange Traded Concepts LLC lifted its stake in shares of Biogen Inc. (NASDAQ:BIIB – Free Report) by 37.5% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 2,286 shares of the biotechnology company’s stock after buying an additional 624 shares during the period. Exchange Traded Concepts LLC’s holdings in Biogen were worth $350,000 […] - 2025-01-31 10:20:57

BIIB institutional holdings

Fatal error: Uncaught mysqli_sql_exception: Column 'Currency_Code' in field list is ambiguous in /var/www/liquidata/show_aggregate_holdings.php:119 Stack trace: #0 /var/www/liquidata/show_aggregate_holdings.php(119): mysqli->query() #1 {main} thrown in /var/www/liquidata/show_aggregate_holdings.php on line 119

Date	ETF ISIN/Name	Num Shares	Book value